Renew Your Membership

Michael D. Shapiro, DO, FACC

Professional Bio:

Michael Shapiro is the inaugural Fred M. Parrish Professor of Cardiology and Molecular Medicine. Wake Forest University Baptist Medical Center. There, he is Director of the Center for Preventive Cardiology. His clinical expertise includes genetic and acquired disorders of cholesterol and triglycerides; atherosclerosis imaging (non-invasive imaging of the heart arteries), genetic predisposition to early heart attacks, cardiovascular risk assessment in apparently healthy individuals, and clinical trials of new cholesterol and triglyceride lowering drugs. Michael has published extensively in the areas of atherosclerosis imaging, lipid disorders, and preventive cardiology. His current investigative research is funded by the NIH and focuses on PCSK9 physiology and its impact on lipoprotein metabolism. Additionally, he is engaged in clinical trials testing novel lipid modulating therapeutics. Michael is a member of numerous boards and national committees and is frequently invited to speak at national and international meetings on topics related to atherosclerosis imaging and the prevention of cardiovascular disease.

General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Amgen Inc.(MODEST), Novartis Corporation(SIGNIFICANT), Regeneron(SIGNIFICANT), Ionis(MODEST), Agepha(MODEST), Aidoc(MODEST), Shanghai Pharma Biotherapeutics (MODEST)

View Full Disclosure

Hey Doc, There's Calcium In My Coronaries⋯ Now What?

Jun 04, 2024   |  Alison Bailey, MD, FACC; Michael D. Shapiro, DO, FACC; Roger S. Blumenthal, MD, FACC

Podcast

In this interview, Michael D. Shapiro, DO, FACC and Roger S. Blumenthal MD, FACC explore CAC scoring and the role of calcium detection in tailoring patient care, personalized risk assessment, and the prevention of future cardiac events.

Clinical Topics: Acute Coronary Syndromes, Dyslipidemia, Noninvasive Imaging, Prevention

Keywords: ACCELLite

Familial Hypercholesterolemia Series - How is FH Treated?

May 13, 2022   |  Michael D. Shapiro, DO, FACC; Salim S. Virani, MD, FACC

Podcast

In this episode, Dr. Michael Shapiro and Dr. Salim Virani discuss the current treatment options for FH, including statin therapy, lifestyle modifications, and non-statin therapy.

Clinical Topics: Diabetes and Cardiometabolic Disease, Dyslipidemia, Prevention, Lipid Metabolism, Nonstatins

Keywords: Cardiovascular Diseases, Cholesterol, LDL, Dyslipidemias, Primary Prevention

Familial Hypercholesterolemia Series - How is FH Detected? Clinical Presentation, Natural History, Diagnosis, & Cascade Screening

May 09, 2022   |  Michael D. Shapiro, DO, FACC; Pam Taub, MD, FACC

Podcast

Editors' Pick

In this episode, Dr. Michael Shapiro and Dr. Pam Taub discuss the clinical presentation, natural history, and diagnosis of familial hypercholesterolemia.

Clinical Topics: Arrhythmias and Clinical EP, Diabetes and Cardiometabolic Disease, Dyslipidemia, Prevention, Genetic Arrhythmic Conditions, Lipid Metabolism, Nonstatins

Keywords: Cardiovascular Diseases, Cholesterol, LDL, Genetic Counseling, Dyslipidemias, Natural History, Primary Prevention, Genetic Testing, Inheritance Patterns

CardiaCast: Familial Hypercholesterolemia Series - What is FH? Epidemiology, Genetics, & Pathophysiology

Apr 22, 2022   |  Michael D. Shapiro, DO, FACC; Christie M. Ballantyne, MD, FACC

Podcast

In this episode, Dr. Michael Shapiro and Dr. Christie Ballantyne discuss the epidemiology, genetics, and pathophysiology of HeFH and HoFH.

Clinical Topics: Arrhythmias and Clinical EP, Cardiovascular Care Team, Diabetes and Cardiometabolic Disease, Dyslipidemia, Prevention, Genetic Arrhythmic Conditions, Lipid Metabolism, Nonstatins

Keywords: CardiaCast, Genetic Testing, Cardiovascular Diseases, Cholesterol, LDL, Genetic Counseling, Dyslipidemias, Mutation, Inheritance Patterns, Primary Prevention

Mitigating ASCVD Risk Among Those Previously Infected with COVID-19

Jun 01, 2021   |  Naveed A. Naz, MD, FACC; Jaideep Patel, MD, FACC; Mahmoud Al Rifai, MD, MPH, FACC; Jeremy S Turlington, MD; Michael D. Shapiro, DO, FACC

Expert Analysis

The cardiovascular effects of the SARS-CoV2 (COVID-19) virus are variable and can range from no appreciable symptoms to cardiogenic or vasodilatory shock mediated by such direct mechanisms as myocarditis and direct myocardial viral infiltration,...

Clinical Topics: Arrhythmias and Clinical EP, Cardiovascular Care Team, COVID-19 Hub, Diabetes and Cardiometabolic Disease, Dyslipidemia, Heart Failure and Cardiomyopathies, Prevention, Implantable Devices, SCD/Ventricular Arrhythmias, Atrial Fibrillation/Supraventricular Arrhythmias, Lipid Metabolism, Nonstatins, Novel Agents, Statins, Diet, Exercise, Hypertension, Smoking

Keywords: Primary Prevention, COVID-19, SARS-CoV-2, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Sedentary Behavior, Smoking Cessation, Renin-Angiotensin System, Calcium, Cardiovascular Diseases, Blood Glucose, Peptidyl-Dipeptidase A, Tobacco Use Disorder, Diet, Mediterranean, Pandemics, Ethnic Groups, Secondary Prevention, Hyperuricemia, Endothelium, Vascular, Adiposity, Influenza, Human, Coronary Vessels, African Americans, Myocarditis, Mental Health, Social Isolation, Postural Orthostatic Tachycardia Syndrome, Virulence, Virus Internalization, Blood Pressure, Depression, Severe Acute Respiratory Syndrome, severe acute respiratory syndrome coronavirus 2, Risk Factors, Minority Groups, Exercise, Immunity, Innate, Atherosclerosis, Smoking, Thrombosis, Dyslipidemias, Diabetes Mellitus, Telemedicine, Delivery of Health Care, Integrated, Delivery of Health Care, Inflammation, Tobacco Use, Risk Assessment, Risk Reduction Behavior, Hypertension, Obesity, Socioeconomic Factors, Arrhythmias, Cardiac, Adaptive Immunity, Hispanic Americans, Vaccination, Anxiety, Lipids, Health Personnel, Immunomodulation, Sodium, Dietary, Hospitals

Results 1-6 of 11